Medical Devices

U.S. FDA grants marketing clearance of cardioPAT surgical blood salvage system

Published in Biotech Business Week, January 16th, 2006

Haemonetics Corp. announced that the redesigned cardioPAT surgical blood salvage system has received 510(k) marketing clearance by the U.S. Food and Drug Administration.

The cardioPAT system allows surgeons to recover blood lost by a cardiovascular surgery patient during and after surgery, and make the blood available for transfusion back to the patient. The process, known as surgical blood salvage or autotransfusion, ensures that a patient is transfused with the safest blood possible, his or her own.

The cardioPAT system was originally regulatory-cleared in January 2005, but Haemonetics identified areas for technology improvement during early...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2006-01-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry